a plethora of endogenous (e.g. ions, lipids, biogenic amines, peptides, and glycoproteins) and exogenous (e.g. odorants, tastants, photons, and therapeutic drugs) ligands. 2 Not surprisingly, GPCRs are involved in the regulation of nearly all processes in our body and their dysfunction contributes to numerous human pathologies. 3, 4 Hence, GPCRs are today's favorite drug targets with ~40% of all current therapeutic molecules acting on members of this protein family.
Binding of an agonist to the extracellular site of the GPCR (i.e. N-terminus, ELs, and/or pocket that is formed by the 7TM helices) induces conformational changes in the 7TM and intracellular domains of the receptor, allowing coupling and activation of specific heterotrimeric G proteins. 5, 6 Activated G proteins dissociate from the GPCR to relay the signal to downstream effector proteins. Subsequent phosphorylation of the intracellular domains of activated GPCRs by GPCR kinases (GRKs) promotes the recruitment of β-arrestins. 7, 8 Bound β-arrestin inhibits G protein signaling by hindering GPCR-G protein coupling and by recruiting proteins involved in receptor endocytosis. However, β-arrestin can also scaffold new signaling cascade components to the activated GPCR, thereby initiating a second wave of intracellular signaling. 9 Most of our cells express several dozen different GPCR subtypes, which can be variably mixed and matched in different cell types, and are consequently responsive to at least a corresponding number of ligands. [10] [11] [12] Importantly, individual ligand-receptor combinations do generally not operate in isolation, but may rather "talk" to each other to come to a balanced cellular response to two or more simultaneous stimuli. This crosstalk can occur at (a combination of) various levels along the GPCR signal transduction pathway. First of all, GPCRs can allosterically interact with each other by forming homomeric or heteromeric (i.e.
between similar or different receptor subtypes, respectively) assemblies (Fig. 1A) .
Secondly, GPCRs can desensitize other GPCRs via second messenger-dependent protein kinases A or C (Fig. 1B) . 7, 13 Thirdly, GPCRs may impair other GPCRs by scavenging shared signaling and/or scaffolding proteins (e.g. G proteins and β-arrestins) that are limiting for receptor signaling (Fig. 1C) . 14, 15 And finally, GPCRs can activate distinct signal transduction pathways that may converge at Heteromerization between different GPCR subtypes can significantly modify functional characteristics of the individual protomers, including subcellular localization, ligand binding co-operativity, and proximal signaling. [17] [18] [19] However, GPCR heteromer-induced changes in biochemical GPCR signaling properties are often difficult to distinguish unambiguously from downstream crosstalk between non-associated GPCR pairs. In this review, we will focus on the question "do
GPCRs that walk hand-in-hand, also talk hand-in-hand?".
GPCR oligomerization. Dimerization and/or higher order oligomerization of otherwise non-functional protomers is a common phenomenom for most cell surface receptor families. Oligomerization of three to five subunits is required to form a ligand-gated ion channel, whereas ligand-induced dimerization is mandatory for activation and signaling of 1TM-domain receptors such as cytokine receptors, receptor tyrosine and serine/threonine kinases. 20, 21 Also class C GPCRs exist and function as obligate dimers. 22, 23 For example, the γ-amino butyric acid (GABA) B receptor consists of two different 7TM subunits GABA B1 and GABA B2 that are nonfunctional when expressed on their own. The GABA B1 subunit is retained in the endoplasmatic reticulum as export through the Golgi is prevented by binding of coat protein I complex (COP1) to the RXR retention motif in its C-tail. 24 However, the GABA B2 subunit masks this COP1 binding site through a coiled-coil interaction of their C-tails, allowing trafficking of the heteromeric GABA B receptor to the cell surface. 25, 26 Moreover, the GABA B subunits have complementary roles in GABAinduced signaling, with GABA binding exclusively to the N-terminal extracellular domain (NTED) of GABA B1 and G proteins exclusively being activated by GABA B2 upon trans-activation of this subunit by the agonist-occupied GABA B1 . [27] [28] [29] [30] Similarly, the umami and sweet taste receptors are heterodimeric assemblies of T1R 3 in combination with T1R 1 or T1R 2 , respectively. 31 Indeed, T1R 3 knockout mice show diminished detection of both umami and sweet taste, whereas only the umami or sweet sensation was affected in T1R 1 and T1R 2 knockout mice, respectively. 31, 32 Finally, the calcium sensing receptor and 8 metabotropic glutamate receptors
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(mGlu) are homodimers in which the two NTEDs are linked by disulfide bonds. 33, 34 Agonist-induced movement of these NTEDs relative to each other results in activation of these receptor dimers. 35 The most widely used biochemical proof for physical interactions between GPCRs is by co-immunoprecipitation (co-IP) of these assemblies from solubilized cells using a specific antibody against one protomer, followed by immunoblotting of the SDS-PAGE-resolved samples using a specific antibody against the other protomer ( Fig.   2A ). 58 Disruption of the cellular integrity may cause aggregation of non-associated receptors, which should be taken into account by comparing cells that co-express energy transfer-mediated acceptor emission. These trFRET fluophores can also be conjugated to antibodies and even more interesting to GPCR ligands. 55, 65 Ligand (antagonist)-based trFRET has very recently successfully been used to detect endogenous oxytoxin receptor oligomers in mammary gland. 55 Even though well designed RET and/or PFC-based experiments may provide compelling evidence for specific GPCR interactions, one has to keep in mind that close proximity rather than physical interactions between proteins is detected. Since only TM1-5 of H 1 R-F Do GPCRs walk hand-in-hand? A large number of class A and C GPCR subtypes are not delivered to the cell surface when transfected in heterologous cells, and it has been proposed that heteromerization of GPCRs that share similar spatiotemporal expression profile in native cells, might be required for proper folding and export of these from the endoplasmic reticulum (ER) to the cell surface (Fig. 3A) . [77] [78] [79] Indeed, the coiled-coil interaction between the C-tails of GABA B1 and GABA B2 is required for cell surface targeting of the heteromeric GABA B receptor, confirming that GPCR homo-and heteromers are formed during early biosynthesis and protein maturation in the ER. Heteromerization of the β 2 -or α 1B -adrenoceptor with the α 1D -adrenoceptor is essential for cell surface targeting of the latter receptor in heterologous cells, whereas co-expression with 26 other related class A GPCRs did not promote surface expression of the α 1D -adrenoceptor. 80, 81 On the contrary, various naturally occurring GPCR splice variants and mutants have been reported to trap co-expressed wildtype counterparts in the ER by forming heteromeric assemblies (Fig. 3A) . [82] [83] [84] [85] [86] [87] [88] For example, natural occurring rat histamine H 3 receptor (H 3 R) splice variants that lack TM7 impair cell surface targeting of wildtype H 3 R. 89 Interestingly, the expression levels of these truncated isoforms and wildtype H 3 R in rat brain are oppositely modulated by the convulsant pentylenetetrazole, resulting in increased H 3 R activity, whereas high-fat diet induced down-regulation of the dominant negative GIP receptor splice variant resulting in an up-regulation of wildtype GIP receptors in obese mice. 90 In addition, dominant negative receptor mutants have been engineered by introducing ER retention signals into the C-tail of GPCRs or site-directed mutation of ER-export motifs. Substitution of the C-tail of the β 2 -adrenoceptor with the C-tail ER-retention motif of GABA B1 resulted in an ER-trapped receptor mutant, which also prevented cell surface targeting of wildtype β 2 -adrenoceptor. 91 Likewise, fusion of the ER-retention motif of the α 2C -adrenoceptor to the C-tail of the CXC-chemokine receptor 1 (CXCR1) impaired its trafficking to the cell surface. 92 Moreover, this ER-retained CXCR1 mutant inhibited cell surface trafficking of wildtype CXCR1 and the closely related CXCR2, by forming homomers and heteromers, respectively. In contrast, cell surface delivery of co-expressed α 1A -adrenoceptor was not affected, which correlated with the observation that CXCR1 and α 1A -adrenoceptor do not form heteromers. The importance of a correct quaternary structure for cell surface delivery was furthermore demonstrated by a α 1B -adrenoceptor mutant in which hydrophobic residues in TM1 and TM4 were Ala-substituted. 59, 60 This TM1-TM4 mutant was trapped in the ER and displayed an altered oligomeric organization in comparison to wildtype receptors as indicated by sequential three-colour FRET analysis.
Convincing evidence for direct physical interactions between
Interestingly, the cell-permeant α 1B -adrenoceptor-antagonist prazosin changed the quaternary structure of TM1-TM4 mutants to an oligomeric organization that resembles wild type α 1B -adrenoceptor. In addition, prazosin acted as pharmacological chaperone by promoting terminal N-glycosylation and maturation, resulting in cell surface delivery of this TM1-TM4 mutant. 59 Several other examples of pharmacological chaperones that restore cell surface delivery of disease-linked receptor mutants have been reported. 93 However, whether this pharmacological rescue involves changes in quaternary receptor organization remain to be investigated.
Collectively, most data suggest that receptor oligomers are pre-assembled in the ER and "walk hand-in-hand" to the cell surface. Obviously, the covalent disulfidebonded homomeric class C GPCRs keep on walking hand-in-hand at the cell surface, whereas the heteromeric GABA B receptor is stabilized by a coiled-coil configuration of the C-tails and direct interactions of the NTEDs. 24 For long, the stability of class A GPCR oligomers has been an enigma, although RET data suggest that most GPCRs remain organized as oligomers (Fig. 3B) receptor. 94, 95 In addition, the Arg-rich motif in IL3 of the dopamine D 2 receptor is involved in a stabilizing electrostatic interaction with a di-glutamate motif in the Cterminus of the serotonin 5-HT 2A and D 1 receptor. 96, 97 Recently, however, the lateral mobility of one protomer was monitored using dual fluorescence recovery after photobleaching (FRAP) microscopy upon antibody-immobilization of the other protomer at the cell surface. 98, 99 To this end, different GFP variants were fused to the N-or C-terminus of the GPCRs. Immobilization of one YFP-β 2 -adrenoceptor almost completely impaired lateral diffusion of at least 4 co-expressed β 2 -adrenoceptor-CFP fusion proteins into the bleached region of the cell membrane, suggesting that receptors form stable higher order homomers. 98 In contrast, the mobility of α1-adrenocepter and D 2 receptor was only modestly affected by the antibody immobilization of their homomeric counterparts, suggesting that these receptors form rather transient homomers (Fig. 3C) . Approximately 30 percent of the M 1 receptors was engaged in homodimers at any given moment, whereas higher order oligomers were never detected for this receptor. 100 Interestingly, the apparent transient nature of β 1 -adrenoceptor, D 2 and M 1 receptor homodimers as observed in these imaging-based studies is in contrast with earlier BRET studies for these receptors, which indicated that the vast majority of these receptors exist as constitutive dimers at nearly physiological expression levels. 62 , but also using 3-color FRET 59, 60 , and sequential RET studies. 95, 106 In addition, GABA B dimers (i.e. homodimers of heterodimers) have been detected by trFRET-SNAP 65 .
Hitherto, regulation of GPCR oligomerization dynamics at the cell surface upon ligand binding remains still controversial (Fig. 3B,C) . For example, the agonist isoproterenol and antagonist propranolol did not affect the stability or amount of β 1 -and β 2 -adrenoceptor homomers in FRAP experiments. Similarly, isoproterenol had little effect on FRET efficiency between purified and reconstituted β 2 -adrenoceptor homomers, while the inverse agonist ICI 118,551 significantly increased the FRET efficiency. 107 On the other hand, isoproterenol dose-dependently increased BRET efficiency between β 2 -adrenergic receptors in living cells. 108 Since RET efficiency is determined by both distance and orientation of donor and acceptor dipole moments, ligand-induced changes in RET intensity do not necessarily reflect de novo formation or dissociation of GPCR oligomers, but may also represent conformational changes in existing oligomers. In addition,
Western blot analyses revealed that agonist or inverse agonist treatment of β 2 -adrenoceptor-expressing membranes shifted the equilibrium towards the homomeric or monomeric state, respectively. 109 Similar inconsistencies have been reported for other GPCRs, and are most presumably related to methodological limitations. Interestingly, agonists increased trFRET between SNAP-tagged M3 receptors but decreased FRET between M 3 receptors that were C-terminally fused to GFP variants. 64 Since encaged lanthanides have no donor dipole constraint, the trFRET efficiency between covalently bound SNAP-tag fluophores is minimally effected by orientation and the observed increase in trFRET may in fact reflect an agonist-induced increase in M 3 receptor oligomerization. 110 If GPCRs exist as (relatively) stable oligomers on the cell surface or become so upon agonist stimulation, one might expect that they keep walking hand-in-hand during internalization (Fig. 3D) . Engineering a "homodimer" between the wildtype and a RASSL (i.e. Receptor Activated Solely by Synthetic Ligands) β 2 -adrenoceptor, it was demonstrated that agonist binding to one of the protomers induces internalization of these "homodimers". 111 On the other hand, agonist binding and activation of both receptor protomers is required for efficient signaling of some other homo-and heteromers. Although a single glutamate molecule is sufficient to promote mGlu 5 homodimer signaling, the binding of two glutamate molecules per homodimer is required for full activation. 128 Heteromerization of the δ-with κ-opioid receptor (δOR and κOR, respectively) resulted in a loss of binding affinity for either δOR-or κOR -selective ligands, whereas partially selective ligands preserved or increased their affinity for the δOR-κOR heteromer. 129 However, positive binding co-operativity was observed when either δOR-and κOR-selective agonists or a combination of selective antagonists were incubated with a non-selective radiolabeled antagonist and δOR-κOR heteromer-expressing membranes, resulting in at least a 50-fold increase in affinity (Fig. 4C) . Surprisingly, only a 10 to 20-fold potentiation in signaling was seen in cells co-expressing δOR and κOR upon co-stimulation with the selective agonists. Even though intermolecular interactions between δOR and κOR are apparent and give rise to a distinctive ligand binding profile, the exact quality and quantity of allosterism within this heteromer seems puzzling. 119 Interestingly, no positive co-operativity was observed between δOR-selective antagonist and κOR-selective agonist on δOR-κOR heteromers. In contrast, δOR-selective antagonists enhance agonist binding and signaling to the µOR protomer within δOR-µOR heteromers. 130 Activated δOR or µOR preferentially activate Gα i proteins as determined by 35 S-GTPγS incorporation in selectively immunoprecipitated G proteins, whereas activated δOR-µOR heteromers interact selectively with Gα z proteins. 131 In addition and in contrast to its homomeric constituents, the δOR-µOR heteromer constitutively recruits β-arrestin2 and is primed to signal through non-G protein-activated pathways. 132 receptors activate of G s and G i/o proteins, respectively, resulting in an opposite regulation of cAMP production by adenylyl cyclase (Fig. 4D) . 135 However, the CB 1 receptor constitutively inhibits agonist-induced µOR signaling, which can be restored by co-incubation with a CB 1 receptor inverse agonist or silencing of the ligand-independent CB 1 receptor signaling by site-directed mutagenesis. 139 Although BRET experiments suggested that CB 1 receptor and µOR exist as heteromers, microscopy studies revealed distinct subcellular localization patterns of both GPCR proteins. 139 The latter implies that CB 1 receptor and µOR are not assembled as heteromers and cross-regulation of µOR signaling by the constitutive active CB 1 receptor is downstream, presumably via G protein scavenging.
The Epstein-Barr virus-encoded GPCR BILF1 forms heteromers with the human chemokine receptor CXCR4. 14, 140 The constitutive active BILF1 also inhibits binding of CXCL12 to CXCR4, whereas a BILF1 mutant, deficient in G protein coupling had a much lesser effect on CXCR4 functioning. Importantly, CXCL12 binding to CXCR4 is highly dependent on the availability of Gα i1 proteins, and co-expression of additional Gα i1 proteins with BILF1 and CXCR4 restored normal functioning of the latter. 14 Although intermolecular inhibition of CXCR4 by BILF1 within a heteromeric complex cannot be ruled out, the rescue of CXCR4 functioning by additional G proteins supports the hypothesis that BILF1 inhibits co-expressed G i/o -coupled
GPCRs by constitutive scavenging of a shared pool of available G i/o proteins.
In addition, GPCRs can impair each other agonist's responsiveness by activating second messenger-dependent protein kinases A or C. These protein kinases can phosphorylate both inactive and active receptors but also G proteins, resulting in reduced responsiveness of multiple GPCR subtypes to their cognate agonists. , and might also apply for the sensitization of G q/11 -coupled orexin-1 receptor by the constitutively active G i/o -coupled CB 1 receptor in a pertussis toxin-sensitive manner, which was suggested by the authors to be a direct consequence of orexin-1/CB 1 receptor heteromerization. 144 Heteromerization between CB 1 and orexin-1 receptor was indeed confirmed in distinct cells and was accompanied with a change in cellular distribution of the orexin-1 receptor. 145 However, in this study CB 1 had only marginal effect on agonist-induced orexin-1 receptor signaling, which was explained as a difference in cellular background.
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Conclusions
Increasing evidence suggests that GPCR oligomerization is essential for cell surface targeting of GPCRs. Whether GPCRs keep on walking hand-in-hand on the cell surface is currently under investigation. Some GPCRs appear to form stable oligomeric complexes, while other spend most of their time wandering around alone. In fact, purified and reconstituted class A GPCR monomers are fully capable to mediate agonist-induced signaling. On the other hand, compelling evidence is available that GPCR oligomers do talk differently hand-in-hand than when they are on their own, for example by shifting from G protein class or from G protein to β-arrestin coupling. However, apparent crosstalk between GPCRs may as well originate more distal from GPCRs by interacting or limiting intracellular signaling network constituents, which may actually affect GPCR properties like agonist binding. Showing that physical GPCR interactions are absolutely required for unique agonist-induced signaling, by actually disrupting them, might therefore be helpful to unambiguously distinguish crosstalk within GPCR heteromers from crosstalk events (far) below these heteromers.
